These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11358955)

  • 1. Blockade of the renin-angiotensin and endothelin systems on progressive renal injury.
    Muenter K; Dashwood MR
    Hypertension; 2001 May; 37(5):E13. PubMed ID: 11358955
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelin antagonism with bosentan: current status and future perspectives.
    Ono K; Matsumori A
    Cardiovasc Drug Rev; 2002; 20(1):1-18. PubMed ID: 12070530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effect of endothelin antagonists in dogs with myocardial infarction.
    Ohta H; Suzuki J; Akima T; Kawai N; Hanada K; Nishikibe M
    J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S255-7. PubMed ID: 9595453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of blockade of the renin-angiotensin and endothelin systems on experimental bronchiolitis obliterans.
    Antus B; Sebe A; Fillinger J; Jeney C; Horvath I
    J Heart Lung Transplant; 2006 Nov; 25(11):1324-9. PubMed ID: 17097496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of the renin-angiotensin and endothelin systems on progressive renal injury.
    Cao Z; Cooper ME; Wu LL; Cox AJ; Jandeleit-Dahm K; Kelly DJ; Gilbert RE
    Hypertension; 2000 Oct; 36(4):561-8. PubMed ID: 11040236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators.
    Krum H; Viskoper RJ; Lacourciere Y; Budde M; Charlon V
    N Engl J Med; 1998 Mar; 338(12):784-90. PubMed ID: 9504938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelin antagonism with bosentan: a review of potential applications.
    Roux S; Breu V; Ertel SI; Clozel M
    J Mol Med (Berl); 1999 Apr; 77(4):364-76. PubMed ID: 10353441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a causal role of the renin-angiotensin system in nitrate tolerance.
    Kurz S; Hink U; Nickenig G; Borthayre AB; Harrison DG; Münzel T
    Circulation; 1999 Jun; 99(24):3181-7. PubMed ID: 10377083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bosentan in essential hypertension.
    Krämer BK; Schweda F; Riegger GA
    N Engl J Med; 1998 Jul; 339(5):346-7. PubMed ID: 9696645
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effects of endothelin blockade on renal expression of angiotensin II type 1 receptor in diabetic hypertensive rats].
    Gu Y; Chen J; Yang H; Zhu W; Lin F; Zhu C; Lin S
    Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(1):10-3. PubMed ID: 11953118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation.
    Herrero I; Torras J; Riera M; Condom E; Coll O; Cruzado JM; Hueso M; Bover J; Lloberas N; Alsina J; Grinyó JM
    Nephrol Dial Transplant; 1999 Apr; 14(4):872-80. PubMed ID: 10328462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endothelin receptors in the control of central nervous system parasitism in Trypanosoma cruzi infection in rats.
    Rachid MA; Teixeira AL; Barcelos LS; Machado CR; Chiari E; Tanowitz HB; Camargos ER; Teixeira MM
    J Neuroimmunol; 2010 Mar; 220(1-2):64-8. PubMed ID: 20116865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Ro 47-0203 and PD155080 on the plasma kinetics, receptor binding and vascular effects of endothelin in the pig.
    Hemsén A; Modin A; Wanecek M; Malmström RE; Weitzberg E
    Eur J Pharmacol; 1996 Dec; 318(2-3):369-76. PubMed ID: 9016927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats.
    Dvorák P; Kramer HJ; Bäcker A; Malý J; Kopkan L; Vanecková I; Vernerová Z; Opocenský M; Tesar V; Bader M; Ganten D; Janda J; Cervenka L
    Kidney Blood Press Res; 2004; 27(4):248-58. PubMed ID: 15286437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paracrine renal endothelin system in rats with liver cirrhosis.
    Hocher B; Zart R; Diekmann F; Rohmeiss P; Distler A; Neumayer HH; Bauer C; Gross P
    Br J Pharmacol; 1996 May; 118(2):220-7. PubMed ID: 8735618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 receptor blockade induces upregulation of renin-angiotensin-aldosterone system expression in terms of blood pressure regulation.
    Bo Yang ; Chen YD; Li TD; Feng QZ
    J Renin Angiotensin Aldosterone Syst; 2010 Jun; 11(2):119-23. PubMed ID: 20093323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bosentan.
    Mathier MA; Ishizawar D
    Expert Opin Pharmacother; 2010 Apr; 11(6):1023-34. PubMed ID: 20307226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin B receptor-mediated vasoconstriction induced by endothelin A receptor antagonist.
    Zhang Y; Oliver JR; Horowitz JD
    Cardiovasc Res; 1998 Sep; 39(3):665-73. PubMed ID: 9861310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of evidence for the interaction between renin-angiotensin-aldosterone system and endothelin in vivo.
    Widimský J; Dvoráková J; Hladovec J; Kopecká J
    Physiol Res; 1996; 45(3):241-3. PubMed ID: 9200216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling.
    Fraccarollo D; Hu K; Galuppo P; Gaudron P; Ertl G
    Circulation; 1997 Dec; 96(11):3963-73. PubMed ID: 9403621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.